Dentsply Sirona (XRAY) Tops Q4 EPS by 4c, FY EPS Guidance Beats

Dentsply Sirona (NASDAQ: XRAY) reported Q4 EPS of $0.58, $0.04 better than the analyst estimate of $0.54. Revenue for the quarter came in at $1.06 billion versus the consensus estimate of $1.03 billion.

GUIDANCE:

Dentsply Sirona sees FY2019 EPS of $2.25-$2.40, versus the consensus of $2.17.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79